Joseph Aumann

759 total citations
18 papers, 523 citations indexed

About

Joseph Aumann is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Joseph Aumann has authored 18 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 12 papers in Physiology and 3 papers in Epidemiology. Recurrent topics in Joseph Aumann's work include Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Asthma and respiratory diseases (7 papers) and Respiratory and Cough-Related Research (5 papers). Joseph Aumann is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), Asthma and respiratory diseases (7 papers) and Respiratory and Cough-Related Research (5 papers). Joseph Aumann collaborates with scholars based in Belgium, Netherlands and Switzerland. Joseph Aumann's co-authors include J.A. van Noord, Achim Mueller, Wim Janssens, Jan Verhaert, Piet J.G. Cornelissen, P. J. G. Cornelissen, Charles Fogarty, Walter Vincken, J.J. Smeets and Pankaj Goyal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Applied Physiology and CHEST Journal.

In The Last Decade

Joseph Aumann

17 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Aumann Belgium 10 490 407 22 21 18 18 523
Rosa Segarra Spain 7 370 0.8× 347 0.9× 7 0.3× 13 0.6× 11 0.6× 12 476
Michelle Henley United States 8 594 1.2× 465 1.1× 9 0.4× 25 1.2× 22 1.2× 14 614
Thomas M. Siler United States 10 501 1.0× 381 0.9× 22 1.0× 14 0.7× 7 0.4× 24 549
Jan Verhaert Belgium 5 495 1.0× 413 1.0× 4 0.2× 19 0.9× 20 1.1× 6 526
Beatriz Seoane Spain 11 387 0.8× 324 0.8× 56 2.5× 11 0.5× 9 0.5× 28 480
Lawrence Korducki United States 13 813 1.7× 697 1.7× 10 0.5× 47 2.2× 19 1.1× 39 841
Anna Unseld Germany 9 297 0.6× 371 0.9× 27 1.2× 9 0.4× 15 0.8× 19 499
В Е Ноников Russia 3 472 1.0× 401 1.0× 6 0.3× 14 0.7× 6 0.3× 5 494
Damon Jack United States 6 512 1.0× 470 1.2× 3 0.1× 19 0.9× 4 0.2× 8 548
R Abrahams United States 7 513 1.0× 424 1.0× 2 0.1× 23 1.1× 12 0.7× 23 529

Countries citing papers authored by Joseph Aumann

Since Specialization
Citations

This map shows the geographic impact of Joseph Aumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Aumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Aumann more than expected).

Fields of papers citing papers by Joseph Aumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Aumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Aumann. The network helps show where Joseph Aumann may publish in the future.

Co-authorship network of co-authors of Joseph Aumann

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Aumann. A scholar is included among the top collaborators of Joseph Aumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Aumann. Joseph Aumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Brandt, Jana De, Chris Burtin, Wim Derave, et al.. (2021). Monomeric CRP is Elevated in Patients with COPD Compared to Non-COPD Control Persons. Journal of Inflammation Research. Volume 14. 4503–4507. 10 indexed citations
2.
Brandt, Jana De, Wim Derave, Frank Vandenabeele, et al.. (2021). Effect of beta-alanine supplementation on muscle carnosine, oxidative and carbonyl stress, antioxidants and physical capacity in patients with COPD. Document Server@UHasselt (UHasselt). OA4224–OA4224. 1 indexed citations
3.
Brandt, Jana De, Chris Burtin, Pascal Pomiès, et al.. (2021). Carnosine, oxidative and carbonyl stress, antioxidants, and muscle fiber characteristics of quadriceps muscle of patients with COPD. Journal of Applied Physiology. 131(4). 1230–1240. 10 indexed citations
4.
Brandt, Jana De, Wim Derave, Frank Vandenabeele, et al.. (2020). Effect of oral beta-alanine supplementation on muscle carnosine in patients with COPD: A double blind, placebo-controlled, randomized trial. Document Server@UHasselt (UHasselt). 4748–4748. 2 indexed citations
5.
Vermeersch, Kristina, Ann Belmans, Kris Bogaerts, et al.. (2019). Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo – a post-hoc analysis of the BACE randomized controlled trial. Respiratory Research. 20(1). 237–237. 13 indexed citations
6.
Brandt, Jana De, Chris Burtin, Frank Vandenabeele, et al.. (2019). Late Breaking Abstract - Muscle carnosine in patients with COPD in comparison to age- and gender matched healthy controls: a cross-sectional study. PA1203–PA1203. 1 indexed citations
7.
Vermeersch, Kristina, Ingel Demedts, Hans Slabbynck, et al.. (2016). The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial. International Journal of COPD. 11. 687–687. 10 indexed citations
8.
Vermeersch, Kristina, Stephanie Everaerts, Vincent Ninane, et al.. (2016). Time-to-treatment failure in the Belgian randomized controlled trial with azithromycin for acute COPD exacerbations requiring hospitalization. OA1506–OA1506. 1 indexed citations
9.
Cuppens, Kristof, et al.. (2015). An unusual cause of difficult weaning in a patient with newly diagnosed small cell lung cancer. SHILAP Revista de lepidopterología. 16. 140–142.
10.
Vincken, Walter, Joseph Aumann, Pankaj Goyal, & Pablo Altman. (2014). Free triple combination of glycopyrronium, indacaterol and ICS improves lung function and dyspnoea versus free double combination of indacaterol and ICS in patients with COPD: A post-hoc analysis from the GLOW6 study. European Respiratory Journal. 44(Suppl 58). P2410–P2410. 3 indexed citations
11.
Vincken, Walter, Joseph Aumann, Hungta Chen, et al.. (2014). Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study. International Journal of COPD. 9. 215–215. 63 indexed citations
12.
13.
14.
LaForce, Craig, Joseph Aumann, L. de Teresa Parreño, et al.. (2010). Sustained 24-hour efficacy of once daily indacaterol (300 μg) in patients with chronic obstructive pulmonary disease: A randomized, crossover study. Pulmonary Pharmacology & Therapeutics. 24(1). 162–168. 24 indexed citations
15.
Noord, J.A. van, Joseph Aumann, Wim Janssens, et al.. (2010). Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms. Respiratory Medicine. 104(7). 995–1004. 83 indexed citations
16.
Noord, J.A. van, et al.. (2008). The efficacy of tiotropium administered via Respimat® Soft Mist™ Inhaler or HandiHaler® in COPD patients. Respiratory Medicine. 103(1). 22–29. 79 indexed citations
17.
Noord, J.A. van, Joseph Aumann, Wim Janssens, et al.. (2006). Effects of Tiotropium With and Without Formoterol on Airflow Obstruction and Resting Hyperinflation in Patients With COPD. CHEST Journal. 129(3). 509–517. 210 indexed citations
18.
Vansteenkiste, Johan, Joost Weyler, Georges Deneffe, et al.. (1995). Bronchuscarcinoom in Vlaanderen.. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosa Segarra Breakdown of academic impact, for papers by Michelle Henley Breakdown of academic impact, for papers by Thomas M. Siler Breakdown of academic impact, for papers by Jan Verhaert Breakdown of academic impact, for papers by Beatriz Seoane Breakdown of academic impact, for papers by Lawrence Korducki Breakdown of academic impact, for papers by Anna Unseld Breakdown of academic impact, for papers by В Е Ноников Breakdown of academic impact, for papers by Damon Jack Breakdown of academic impact, for papers by R Abrahams
Rankless by CCL
2026